Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Fluorouracil + Calcipotriene for sBCC and SCCis
NCT05381597Phase 3Recruiting
- Sponsor
- Boston University
- Start
- Oct 2022
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of calcipotriol in basal cell carcinoma (BCC), squamous cell carcinoma (SCC), sponsored by Boston University. Started Oct 2022; status: recruiting.
02
Drugs
calcipotriol
03
Conditions
basal cell carcinoma (BCC)squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT05381597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05381597.